Colleen Deboer
Adult Health · New York, NYNPI 1902953904
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,918 of the $2,266 with a category attached, or 84.6%. 19 manufacturers reported payments, led by Daiichi Sankyo Inc. at 24.3% of the total. Reporting peaked in 2023 at $936 and has fallen 80.6% since, to $182 in 2025.
Across 82 payments — averaging $27.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$550
- Novartis$410
- Incyte Corporation$182
- Astellas Pharma US Inc$174
- Seagen Inc.$141
- Amgen$135
- plus $673 from 13 others
What the payments were for
- Food & beverage$1,91885%
- Education$34815%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 23 | $550 |
| Novartis | 21 | $410 |
| Incyte Corporation | 3 | $182 |
| Astellas Pharma US Inc | 2 | $174 |
| Seagen Inc. | 5 | $141 |
| Amgen(2 entities) | 6 | $135 |
| AstraZeneca(2 entities) | 2 | $113 |
| Bayer | 1 | $111 |
| Pfizer | 4 | $101 |
| Merck | 3 | $62 |
| Sanofi | 2 | $50 |
| Gilead | 1 | $50 |
| AbbVie | 2 | $46 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Johnson & Johnson | 1 | $28 |
| ADC Therapeutics America, Inc. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $21 |
| Tolmar Pharmaceuticals, Inc. | 1 | $17 |
| Sobi, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,266 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other adult health in New York
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
- Hyo Jin KangNew York$19K
- Monica RicheyNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.